TMCI Stock Analysis: Buy, Sell, or Hold?
TMCI - Treace Medical Concepts, Inc. Common Stock
$2.78
-0.06 (-2.11%)
▼
5d:
+4.51%
30d:
+52.75%
90d:
+38.31%
HOLD
MODERATE Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When TMCI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: TMCI is 9.0% above its trading range ($2.55). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: TMCI is 9.0% above its trading range ($2.55). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: TMCI is currently trading at $2.78, which is considered extended relative to its 30-day fair value range of $1.77 to $2.55.
Technical Outlook: Technically, TMCI is in a downtrend. Immediate support is located at $1.80, while resistance sits at $2.99.
Market Sentiment: TMCI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (81th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $4.00 (+43.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TMCI is in a downtrend. Immediate support is located at $1.80, while resistance sits at $2.99.
Market Sentiment: TMCI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (81th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $4.00 (+43.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.77 -
$2.55
Company Quality Score
57/100
(HOLD)
Options IV Signal
81th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BEARISH: Price extended above range (+9.0% above its trading range)
- BEARISH: Options expensive (IV 81th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 43.9% below Wall St target ($4.00)
Trading Range Analysis
30-Day Trading Range
$1.77 -
$2.55
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.89
(32.0%)
Support & Resistance Levels
Support Level
$1.81
Resistance Level
$2.99
Current Trend
Downtrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.09
Wall Street Target
$4.00
(+43.9%)
Revenue Growth (YoY)
-10.2%
Profit Margin
-29.4%
Share & Embed Analysis
Last updated: May 25, 2026 3:33 AM ET
Data refreshes hourly during market hours. Next update: 4:33 AM
Data refreshes hourly during market hours. Next update: 4:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TMCI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$83 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$82 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$107 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 67 BUY |